fbpx

BLOG

January 16, 2025

Ketamine-based therapies, including Spravato (esketamine) and intravenous (IV) ketamine, have revolutionized the treatment of treatment-resistant depression (TRD) and other mood disorders. These

Read More
January 3, 2025

Concentration is an essential cognitive function that allows us to focus on tasks, process information, and navigate daily life. However, difficulties with

Read More
August 6, 2024

Preparing for IV Ketamine or Spravato Treatment: A Comprehensive Guide For individuals with treatment-resistant depression (TRD) or severe depressive symptoms, IV ketamine

Read More
July 31, 2024

Spravato vs. IV Ketamine: Similarities and Differences in Treating Depression The landscape of depression treatment has been significantly broadened with the introduction

Read More
July 25, 2024

Exploring TMS: A Breakthrough for Patients with Treatment-Resistant Depression and OCD In the landscape of mental health treatment, medication has long been

Read More
July 6, 2024

Prominent Advocates for Ketamine in Mental Health Treatment As the understanding of mental health evolves, so does the exploration of innovative treatments.

Read More
May 10, 2024

In the pursuit of innovative treatments for depression, researchers are delving into the potential synergy between Nicotinamide Adenine Dinucleotide (NAD+) and Ketamine.

Read More
April 9, 2024

In the labyrinth of depression treatment, S-adenosyl methionine (SAMe) emerges as a beacon of hope, shedding light on its potential to alleviate

Read More
>